Applied Behavior Analysis — CPB 0554 | AETNA Coverage Update

Aetna modified CPB 0554 covering Applied Behavior Analysis, effective November 27, 2025. CPT codes 97151–97158 are not covered for Down syndrome without ASD co-morbidity or for any other non-ASD indication. Here's what billing teams need to do.

Aetna, a CVS Health company, updated its Applied Behavior Analysis coverage policy under CPB 0554 in the Aetna system. The policy draws a hard line: ABA is covered for autism spectrum disorder (ASD) under a separate policy, CPB 0648, but CPT codes 97151, 97152, 97153, 97154, 97155, 97156, 97157, and 97158 are explicitly excluded for all other diagnoses — including Down syndrome (ICD-10 Q90.0–Q90.9) unless ASD is a documented co-morbidity. If your practice bills ABA services for patients with Down syndrome or other developmental diagnoses, this change directly threatens your reimbursement.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna (Aetna, a CVS Health company)
Policy	Applied Behavior Analysis
Policy Code	CPB 0554
Change Type	Modified
Effective Date	November 27, 2025
Impact Level	High
Specialties Affected	Behavioral health, developmental pediatrics, ABA therapy providers
Key Action	Audit any ABA claims billed with Q90.x diagnosis codes and confirm ASD co-morbidity is documented before billing CPT 97151–97158

---

Aetna Applied Behavior Analysis Coverage Criteria and Medical Necessity Requirements 2025

The Aetna ABA coverage policy splits into two distinct tracks. Covered ABA — meaning services where medical necessity can be established — lives in CPB 0648, which handles ASD indications. CPB 0554 is the other side of that coin. It defines what Aetna will not cover and why.

Under CPB 0554, Aetna classifies ABA as experimental, investigational, or unproven for Down syndrome in the absence of an ASD co-morbidity. The stated reason is insufficient evidence in the peer-reviewed literature. That language matters for denial and appeals — it signals Aetna won't move on medical necessity arguments unless you're documenting a concurrent ASD diagnosis.

The policy extends that same experimental classification to all other non-ASD indications. That's a broad sweep. If a patient carries a diagnosis not classified under F84.x, ABA billing against CPT 97151–97158 will not meet Aetna's medical necessity threshold under this policy.

ABA services for ASD diagnoses are governed by CPB 0648, not CPB 0554. Make sure your billing team understands which policy applies before submitting claims or seeking prior authorization for ASD patients. These are general billing practice recommendations based on how these two policies interact — not statements made directly by CPB 0554.

---

Aetna ABA Therapy Exclusions and Non-Covered Indications

This is where CPB 0554 does most of its work. Two categories of patients are explicitly excluded from ABA coverage under this policy.

Down syndrome without ASD co-morbidity. Patients diagnosed with Down syndrome (Q90.0–Q90.9) are not eligible for covered ABA services unless there is a documented ASD diagnosis alongside the Down syndrome. The co-morbidity requirement is strict. Aetna's position is that the evidence base for ABA in Down syndrome — independent of autism — is insufficient to support coverage. If your practice serves patients with Down syndrome and uses ABA CPT codes, check every chart for a confirmed ASD diagnosis.

All other non-ASD indications. This is the broader exclusion. Aetna's language — "all other non-ASD indications" — means any condition not classified under pervasive developmental disorders (F84.x) is excluded. That language is broad. It covers any behavioral or developmental diagnosis outside the F84.x code range — think of it as a catch-all, not a narrow carve-out. The claim denial risk here is high and predictable. (These are illustrative examples of how broad that language is — CPB 0554 does not enumerate specific excluded conditions.)

The real issue with this policy isn't ambiguity — it's scope. "All other non-ASD indications" is about as wide as exclusion language gets. If you've been billing ABA CPT codes for a mixed diagnostic population, audit those claims now. Don't wait for a denial pattern to surface in your AR.

---

Coverage Indications at a Glance

---

Aetna Applied Behavior Analysis Billing Guidelines and Action Items 2025

These are the concrete steps your billing team needs to take based on the CPB 0554 policy change effective November 27, 2025.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Applied Behavior Analysis Under CPB 0554

Not Covered CPT Codes (Non-ASD Indications)

These CPT codes are explicitly not covered under CPB 0554 for the indications listed in the policy.

Other CPT Codes Related to CPB 0554

Code	Type	Description Copy
0362T	CPT Category III	Behavior identification supporting assessment, each 15 minutes of technician's time face-to-face with patient
0373T	CPT Category III	Adaptive behavior treatment with protocol modification, each 15 minutes of technician's time face-to-face with patient

Key ICD-10-CM Diagnosis Codes

Autism Spectrum Disorder — Pervasive Developmental Disorders (F84.x)

These codes are referenced in CPB 0554 in the context of ASD co-morbidity requirements. ABA coverage for ASD routes through CPB 0648.

Down Syndrome (Q90.x)

These codes trigger the co-morbidity requirement. Without a concurrent F84.x diagnosis, claims with these codes and ABA CPT codes will be denied under CPB 0554.

---